The Scottish Government has confirmed it will inoculate boys aged 12 and 13 from the HPV virus in the next school year.
"In time, this will lead to a significant reduction in cancers of the anus, penis and head and neck".
Cervical cancer is the most common cancer in women under the age of 35, killing around 850 people every year.
Boys will receive their first jab in Year Eight, with the second dose between six and 24 months after.
In a statement, she added: "This universal programme offers us the opportunity to make HPV-related diseases a thing of the past and build on the success of the girls' programme". He said 'We're rolling out the highly effective HPV vaccine to boys across the country to protect more girls from cervical cancer.' Twitter users were quick to comment that Hancock has failed to address the fact that the jab will also save men from developing some types of cancer, and so it's beneficial for both sexes, instead of just girls. "It's important not to delay vaccination, as the vaccine may be less effective as adolescents get older", Dr Mary Ramsay of Public Health England, said.
A total of 10 million dose of the HPV vaccine have been given to young women, meaning 80 per of those age 15 to 24 have received it.
Figures from Public Health England (PHE) showed infections of some strains of HPV in youngsters aged 16-21 have fallen by 86 per cent in England in December.
HPV causes 99% of cervical cancers as well as 90% of anal, about 70% of vaginal and vulvar cancers and more than 60% of penile cancers.
Giving 12 and 13-year-old boys the HPV vaccine could help to prevent 29,000 cases of cancer among men over the next 40 years, according to health officials.
"We now know HPV can be the cause of several other cancers as well as cervical and getting eligible people vaccinated will save lives in years to come".
Programmes like this are at the heart of our work to help people live longer, healthier lives through the NHS Long Term Plan and I would encourage everyone who is eligible to take up this potentially life-saving vaccine. This follows the recommendation by the Joint Committee on Vaccination and Immunisation.
The jab protects against human papillomavirus, which causes many throat cancer, and anal cancers.
The boys can be eligible from the start of the new faculty year, 11 years after women have been first vaccinated.
Boys will need two doses of the jab for full protection.
Studies show the vaccine protects against infection for at least 10 years, but experts predict the protection could be lifelong.
"Given the growing body of evidence that HPV is also responsible for a range of cancers that can affect men, this is a very important step". This resulted in the HPV rate for young women dropping from 22% to 1% - and similar trends are being reported in boys.
The human papilloma virus (HPV) vaccine now used in the NHS vaccination programme is called Gardasil.
Unfortunately, there is still a stigma associated with HPV infections, as is the case with other sexually transmitted infections.
The estimates produced by the University of Warwick are based on a comparison between there being no HPV vaccination programme and the girls programme starting in 2008 with the addition of boys in 2017.